Neuronetics, Inc.
STIM US
STIM USNeuronetics, Inc.
United States Composite2.02
USD
-0.04
(-1.94%)
Next Earnings
November 7
Held by Insiders
6.04%
Held by Institutions
73.12%
Short % of Float
1.27%
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Mr. Keith J. Sullivan
- Full Time Employees
- 211
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Address
- 3222 Phoenixville Pike Malvern PA United States 19355
- Website
- neurostar.com
- Business
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.